Baader Bank Aktiengesellschaft’s XORTX Therapeutics XRTX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio XRTX Stock Details XRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,746	Closed	-$4.74K	–	563
2025 Q4	$4.74K	Buy	+3,746	New	+$12.4K	﹤0.01%	432

Other funds holding XRTX

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Baader Bank Aktiengesellschaft's XRTX Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft sold out of XORTX Therapeutics (XRTX) in Q1 2026, closing a stake of 3,746 shares — an estimated $4.74K sold.

Baader Bank Aktiengesellschaft first reported a position in XRTX in Q4 2025 and held it in 1 quarter. The position peaked at $4.74K in Q4 2025. 3 funds tracked by Wall St. Rank hold XRTX as of Q1 2026.

Baader Bank Aktiengesellschaft reported no remaining XORTX Therapeutics position as of Q1 2026 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 3,746 XORTX Therapeutics shares in Q1 2026, an estimated $4.74K.
Baader Bank Aktiengesellschaft first reported a position in XORTX Therapeutics in Q4 2025 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's XORTX Therapeutics position peaked at $4.74K in Q4 2025.
3 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.